Prevalence and drug susceptibility of clinical Candida species in nasopharyngeal cancer patients in Vietnam
In the nature, Candida species are normal inhabitants and can be observed in a wide variety of vertebrates. In humans, especially for cancer patients who fall prey to opportunistic pathogens, this group of susceptible multi-drug resistant and biofilm-forming yeasts, are among the commonest ones. In...
Saved in:
Published in: | One health Vol. 18; p. 100659 |
---|---|
Main Authors: | , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Netherlands
Elsevier B.V
01-06-2024
Elsevier |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | In the nature, Candida species are normal inhabitants and can be observed in a wide variety of vertebrates. In humans, especially for cancer patients who fall prey to opportunistic pathogens, this group of susceptible multi-drug resistant and biofilm-forming yeasts, are among the commonest ones. In this study, Candida species in 76 oral lesion samples from Vietnamese nasopharyngeal-cancer patients were isolated, morphologically identified using CHROMagar™, germ tube formation, and chlamydospore formation tests, and molecularly confirmed by PCR-RFLP. The drug susceptibility of these isolates was then tested, and the gene ERG11 was DNA sequenced to investigate the mechanism of resistance.
The results showed that Candida albicans remained the most prevalent species (63.16% of the cases), followed by Candida glabrata, Candida tropicalis, and Candida krusei. The rates of resistance of non-albicans Candida for tested drugs were 85.71%, 53.57%, and 57.14% to fluconazole, clotrimazole, and miconazole, respectively. Although the drug-resistance rate of Candida albicans was lower than that of non-albicans Candida, it was higher than expected, suggesting an emerging drug-resistance phenomenon. Furthermore, ERG11 DNA sequencing revealed different mutations (especially K128T), implying the presence of multiple resistance mechanisms. Altogether, the results indicate an alarming drug-resistance situation in Candida species in Vietnamese cancer patients and emphasize the importance of species identification and their drug susceptibility prior to treatment. |
---|---|
AbstractList | In the nature, Candida species are normal inhabitants and can be observed in a wide variety of vertebrates. In humans, especially for cancer patients who fall prey to opportunistic pathogens, this group of susceptible multi-drug resistant and biofilm-forming yeasts, are among the commonest ones. In this study, Candida species in 76 oral lesion samples from Vietnamese nasopharyngeal-cancer patients were isolated, morphologically identified using CHROMagar™, germ tube formation, and chlamydospore formation tests, and molecularly confirmed by PCR-RFLP. The drug susceptibility of these isolates was then tested, and the gene ERG11 was DNA sequenced to investigate the mechanism of resistance.The results showed that Candida albicans remained the most prevalent species (63.16% of the cases), followed by Candida glabrata, Candida tropicalis, and Candida krusei. The rates of resistance of non-albicans Candida for tested drugs were 85.71%, 53.57%, and 57.14% to fluconazole, clotrimazole, and miconazole, respectively. Although the drug-resistance rate of Candida albicans was lower than that of non-albicans Candida, it was higher than expected, suggesting an emerging drug-resistance phenomenon. Furthermore, ERG11 DNA sequencing revealed different mutations (especially K128T), implying the presence of multiple resistance mechanisms. Altogether, the results indicate an alarming drug-resistance situation in Candida species in Vietnamese cancer patients and emphasize the importance of species identification and their drug susceptibility prior to treatment. In the nature, species are normal inhabitants and can be observed in a wide variety of vertebrates. In humans, especially for cancer patients who fall prey to opportunistic pathogens, this group of susceptible multi-drug resistant and biofilm-forming yeasts, are among the commonest ones. In this study, species in 76 oral lesion samples from Vietnamese nasopharyngeal-cancer patients were isolated, morphologically identified using CHROMagar™, germ tube formation, and chlamydospore formation tests, and molecularly confirmed by PCR-RFLP. The drug susceptibility of these isolates was then tested, and the gene was DNA sequenced to investigate the mechanism of resistance. The results showed that remained the most prevalent species (63.16% of the cases), followed by , , and . The rates of resistance of for tested drugs were 85.71%, 53.57%, and 57.14% to fluconazole, clotrimazole, and miconazole, respectively. Although the drug-resistance rate of was lower than that of , it was higher than expected, suggesting an emerging drug-resistance phenomenon. Furthermore, DNA sequencing revealed different mutations (especially K128T), implying the presence of multiple resistance mechanisms. Altogether, the results indicate an alarming drug-resistance situation in species in Vietnamese cancer patients and emphasize the importance of species identification and their drug susceptibility prior to treatment. In the nature, Candida species are normal inhabitants and can be observed in a wide variety of vertebrates. In humans, especially for cancer patients who fall prey to opportunistic pathogens, this group of susceptible multi-drug resistant and biofilm-forming yeasts, are among the commonest ones. In this study, Candida species in 76 oral lesion samples from Vietnamese nasopharyngeal-cancer patients were isolated, morphologically identified using CHROMagar™, germ tube formation, and chlamydospore formation tests, and molecularly confirmed by PCR-RFLP. The drug susceptibility of these isolates was then tested, and the gene ERG11 was DNA sequenced to investigate the mechanism of resistance. The results showed that Candida albicans remained the most prevalent species (63.16% of the cases), followed by Candida glabrata , Candida tropicalis , and Candida krusei . The rates of resistance of non-albicans Candida for tested drugs were 85.71%, 53.57%, and 57.14% to fluconazole, clotrimazole, and miconazole, respectively. Although the drug-resistance rate of Candida albicans was lower than that of non-albicans Candida , it was higher than expected, suggesting an emerging drug-resistance phenomenon. Furthermore, ERG11 DNA sequencing revealed different mutations (especially K128T), implying the presence of multiple resistance mechanisms. Altogether, the results indicate an alarming drug-resistance situation in Candida species in Vietnamese cancer patients and emphasize the importance of species identification and their drug susceptibility prior to treatment. In the nature, Candida species are normal inhabitants and can be observed in a wide variety of vertebrates. In humans, especially for cancer patients who fall prey to opportunistic pathogens, this group of susceptible multi-drug resistant and biofilm-forming yeasts, are among the commonest ones. In this study, Candida species in 76 oral lesion samples from Vietnamese nasopharyngeal-cancer patients were isolated, morphologically identified using CHROMagar™, germ tube formation, and chlamydospore formation tests, and molecularly confirmed by PCR-RFLP. The drug susceptibility of these isolates was then tested, and the gene ERG11 was DNA sequenced to investigate the mechanism of resistance. The results showed that Candida albicans remained the most prevalent species (63.16% of the cases), followed by Candida glabrata, Candida tropicalis, and Candida krusei. The rates of resistance of non-albicans Candida for tested drugs were 85.71%, 53.57%, and 57.14% to fluconazole, clotrimazole, and miconazole, respectively. Although the drug-resistance rate of Candida albicans was lower than that of non-albicans Candida, it was higher than expected, suggesting an emerging drug-resistance phenomenon. Furthermore, ERG11 DNA sequencing revealed different mutations (especially K128T), implying the presence of multiple resistance mechanisms. Altogether, the results indicate an alarming drug-resistance situation in Candida species in Vietnamese cancer patients and emphasize the importance of species identification and their drug susceptibility prior to treatment. |
ArticleNumber | 100659 |
Author | Vo, Thanh-Hoa Le, Minh-Tri Nguyen, Bac V.G. Tran-Nguyen, Viet-Khoa Nguyen, Phuoc-Vinh Vu, Thao Thanh Nguyen, Hau H.N. |
Author_xml | – sequence: 1 givenname: Bac V.G. surname: Nguyen fullname: Nguyen, Bac V.G. organization: Faculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Viet Nam – sequence: 2 givenname: Hau H.N. surname: Nguyen fullname: Nguyen, Hau H.N. organization: Faculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Viet Nam – sequence: 3 givenname: Thanh-Hoa surname: Vo fullname: Vo, Thanh-Hoa organization: School of Medicine, Vietnam National University Ho Chi Minh City, Ho Chi Minh City, Viet Nam – sequence: 4 givenname: Minh-Tri surname: Le fullname: Le, Minh-Tri organization: School of Medicine, Vietnam National University Ho Chi Minh City, Ho Chi Minh City, Viet Nam – sequence: 5 givenname: Viet-Khoa surname: Tran-Nguyen fullname: Tran-Nguyen, Viet-Khoa organization: Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, Marseille, France – sequence: 6 givenname: Thao Thanh surname: Vu fullname: Vu, Thao Thanh organization: Faculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Viet Nam – sequence: 7 givenname: Phuoc-Vinh surname: Nguyen fullname: Nguyen, Phuoc-Vinh email: npvinh@medvnu.edu.vn organization: School of Medicine, Vietnam National University Ho Chi Minh City, Ho Chi Minh City, Viet Nam |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38179314$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kUtvEzEQxy1URB_0GyC0Ry4Jfuz6cQGhCGilSnAArtasPZs4bLyLvYnUb4-TLVV74eLx4z-_Gc__kpzFISIhbxhdMsrk--2ynDf9tOSUi3JFZWNekAsuGr5QitVnT_bn5DrnLaWUNVw3vHlFzoVmyghWX5Df3xMeoMfosILoK5_26yrvs8NxCm3ow3RfDV3l-hCDg75aFVHwUOURXcBchVhFyMO4gXQf11gUDgorVSNMAeN0UvwKOEXYvSYvO-gzXj_EK_Lzy-cfq5vF3bevt6tPdwtXKzMtXOOYNqyscAxUKOa0Vh6ZAMoN7Wpea6nBtN5LVwvUXskWpaYgJW-8uCK3M9cPsLVjCrvSnB0g2NPFkNYW0hRcj1YxCp0WLTWuYLkEphwHpxg3BhuvCuvjzBr37Q69K19K0D-DPn-JYWPXw8EyqiRTShfCuwdCGv7sMU92F8p4-x4iDvtsueHaNFILXqT1LHVpyDlh91iHUXv03ZbuT77bo-929r2kvX3a42PSP5eL4MMswDL1Q8BkczGv2ORDQjeVsYT_V_gLiD3DYA |
Cites_doi | 10.1155/2017/1976273 10.1155/2018/3086586 10.1186/s12903-021-01721-x 10.1177/0956462414548906 10.3390/pathogens11111289 10.1136/pmj.78.922.455 10.4103/jcrt.JCRT_581_18 10.1111/myc.12330 10.1186/1471-2180-8-135 10.1093/mmy/myaa049 10.1007/s00203-015-1146-8 10.1128/AAC.41.7.1482 10.1128/IAI.67.10.5514-5517.1999 10.3390/life12111677 10.2147/IDR.S360973 10.1111/1567-1364.12042 10.1093/mmy/myz135 10.1093/mmy/myv085 10.1086/596757 10.1038/srep36157 10.1097/MAJ.0b013e3181f54dab 10.4103/0973-029X.141325 10.1002/1097-0142(19821215)50:12<2780::AID-CNCR2820501215>3.0.CO;2-P 10.1080/13693780601059936 10.1016/j.archger.2016.04.001 10.1007/s11046-012-9520-4 10.3390/data2030026 10.1128/JCM.38.8.3016-3021.2000 10.1128/AAC.00926-08 10.1038/nmeth.2019 10.1186/s12879-017-2916-5 10.1128/JCM.01811-20 10.1128/JCM.36.4.1157-1159.1998 |
ContentType | Journal Article |
Copyright | 2023 2023 The Authors. Published by Elsevier B.V. 2023 The Authors. Published by Elsevier B.V. 2023 |
Copyright_xml | – notice: 2023 – notice: 2023 The Authors. Published by Elsevier B.V. – notice: 2023 The Authors. Published by Elsevier B.V. 2023 |
DBID | 6I. AAFTH NPM AAYXX CITATION 7X8 5PM DOA |
DOI | 10.1016/j.onehlt.2023.100659 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals |
DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: http://www.doaj.org/ sourceTypes: Open Website |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Public Health |
EISSN | 2352-7714 |
EndPage | 100659 |
ExternalDocumentID | oai_doaj_org_article_710af83b09cf4226a17c2ac71299e5d7 10_1016_j_onehlt_2023_100659 38179314 S2352771423001799 |
Genre | Journal Article |
GroupedDBID | .1- .FO 0R~ 0SF 1P~ 457 53G 6I. AACTN AAEDW AAFTH AALRI AAXUO ABMAC ACGFS ADBBV ADEZE ADVLN AEXQZ AFRHN AFTJW AGHFR AITUG AJUYK ALMA_UNASSIGNED_HOLDINGS AMRAJ AOIJS BCNDV EBS EJD FDB GROUPED_DOAJ HYE IXB KQ8 M~E NCXOZ O9- OK1 ROL RPM SSZ Z5R AFJKZ NPM AAYXX CITATION 7X8 5PM |
ID | FETCH-LOGICAL-c479t-c5c18915c1a89150371c887de13a0290f424868a9bdd6c43e8d76be680a6625d3 |
IEDL.DBID | RPM |
ISSN | 2352-7714 |
IngestDate | Tue Oct 22 15:00:35 EDT 2024 Tue Sep 17 21:29:00 EDT 2024 Sun Sep 29 07:21:46 EDT 2024 Thu Sep 26 21:01:15 EDT 2024 Sat Nov 02 12:11:04 EDT 2024 Sat Jul 27 15:42:08 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | ERG11 Candida species Drug-resistance susceptibility Antifungal agents |
Language | English |
License | This is an open access article under the CC BY-NC-ND license. 2023 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c479t-c5c18915c1a89150371c887de13a0290f424868a9bdd6c43e8d76be680a6625d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10761778/ |
PMID | 38179314 |
PQID | 2928956832 |
PQPubID | 23479 |
PageCount | 1 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_710af83b09cf4226a17c2ac71299e5d7 pubmedcentral_primary_oai_pubmedcentral_nih_gov_10761778 proquest_miscellaneous_2928956832 crossref_primary_10_1016_j_onehlt_2023_100659 pubmed_primary_38179314 elsevier_sciencedirect_doi_10_1016_j_onehlt_2023_100659 |
PublicationCentury | 2000 |
PublicationDate | 2024-06-01 |
PublicationDateYYYYMMDD | 2024-06-01 |
PublicationDate_xml | – month: 06 year: 2024 text: 2024-06-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | One health |
PublicationTitleAlternate | One Health |
PublicationYear | 2024 |
Publisher | Elsevier B.V Elsevier |
Publisher_xml | – name: Elsevier B.V – name: Elsevier |
References | Worthington, Eden, Clarkson (bb0190) 2004 Katz (bb0100) 2021; 1985 Castelo-Branco, Paiva, Teixeira, Caetano, Guedes, Cordeiro, Brilhante, Rocha, Sidrim (bb0110) 2020; 58 Paul, Kannan, Mohanram (bb0225) 2019; 5 Sanguinetti, Posteraro, Lass-Flörl (bb0195) 2015; 58 Xiang, Liu, Ni, Wang, Shi, Wei, Ni, Ge (bb0060) 2013; 13 Whaley, Berkow, Rybak, Nishimoto, Barker, Rogers (bb0055) 2016; 7 WHO TEAM (bb0030) 2022 Jain, Shah, Chandolia, Mathur, Chauhan, Chawda, Mosby, Bhagalia (bb0095) 2016; 10 Fraser, Brown, Houldsworth, Borman, Johnson (bb0175) 2015 Akpan, Morgan (bb0005) 2002; 78 Hamza, Matee, Moshi, Simon, Mugusi, Mikx, Helderman, Rijs, van der Ven, Verweij (bb0200) 2008; 8 White (bb0070) 1997; 41 Xu, Sheng, Zhao, Chen, Li (bb0230) 2015; 197 Rai, Misra, Panda, Sokolowski, Mishra, Das, Lapinska (bb0050) 2022; 12 DeGregorio, Lee, Ries (bb0090) 1982; 50 Fothergill (bb0120) 2012 Benito-Cruz, Aranda-Romo, López-Esqueda, de la Rosa-García, Rosas-Hernández, Sánchez-Vargas (bb0025) 2016; 65 Wahyuningsih, Freisleben, Sonntag, Schnitzler (bb0115) 2000; 38 Schindelin, Arganda-Carreras, Frise, Kaynig, Longair, Pietzsch, Preibisch, Rueden, Saalfeld, Schmid, Tinevez, White, Hartenstein, Eliceiri, Tomancak, Cardona (bb0130) 2012; 9 Quindós, Gil-Alonso, Marcos-Arias, Sevillano, Mateo, Jauregizar, Eraso (bb0040) 2019; 24 González Gravina, González de Morán, Zambrano, Lozano Chourio, Rodríguez de Valero, Robertis, Mesa (bb0180) 2007; 12 A.N. R, N.B. Rafiq (bb0035) 2022 Jayachandran, Katragadda, Thyagarajan, Vajravelu, Manikesi, Kaliappan, Jayachandran (bb0085) 2016; 2016 Singh, Verma, Murari, Agrawal (bb0010) 2014; 18 Gaitán-Cepeda, Sánchez-Vargas, Castillo (bb0075) 2015; 26 Černáková, Líšková, Lengyelová, Rodrigues (bb0020) 2022; 58 Talukdar, Barman, Sarma, Krishnatreya, Sharma, Kataki (bb0185) 2020; 16 Aslani, Janbabaei, Abastabar, Meis, Babaeian, Khodavaisy, Boekhout, Badali (bb0205) 2018; 18 Pappas, Kauffman, Andes, Benjamin, Calandra, Edwards, Filler, Fisher, Kullberg, Ostrosky-Zeichner, Reboli, Rex, Walsh, Sobel, Infectious Diseases Society of America (bb0045) 2009; 48 Borman, Fraser, Johnson (bb0135) 2021; 59 Mahdavi Omran, Rezaei Dastjerdi, Zuashkiani, Moqarabzadeh, Taghizadeh-Armaki (bb0215) 2018; 2018 Sonneborn, Bockmühl, Ernst (bb0145) 1999; 67 Matare, Nziramasanga, Gwanzura, Robertson (bb0140) 2017; 2017 Urbanek, Łapińska, Derkacz, Krasowska (bb0220) 2022; 11 Al-Yasiri, Normand, L’Ollivier, Lachaud, Bourgeois, Rebaudet, Piarroux, Mauffrey, Ranque (bb0105) 2016; 6 Ingle, Kodgire, Shiradhone, Patil, Zore (bb0150) 2017; 2 Merlino, Tambosis, Veal (bb0170) 1998; 36 Pincus, Orenga, Chatellier (bb0160) 2007; 45 Burton, Swiatlo, Shah (bb0165) 2011; 341 Taylor, Brizuela, Raja (bb0155) 2023 Borman, Johnson (bb0015) 2021; 59 (bb0125) 2018 Chitapanarux, Wongsrita, Sripan, Kongsupapsiri, Phakoetsuk, Chachvarat, Kittidachanan (bb0080) 2021; 21 Carvalhinho, Costa, Coelho, Martins, Sampaio (bb0210) 2012; 174 Odiba, Durojaye, Ezeonu, Mgbeahuruike, Nwanguma (bb0235) 2022; 15 Tsao, Rahkhoodaee, Raymond (bb0065) 2009; 53 DeGregorio (10.1016/j.onehlt.2023.100659_bb0090) 1982; 50 Al-Yasiri (10.1016/j.onehlt.2023.100659_bb0105) 2016; 6 Aslani (10.1016/j.onehlt.2023.100659_bb0205) 2018; 18 Merlino (10.1016/j.onehlt.2023.100659_bb0170) 1998; 36 Worthington (10.1016/j.onehlt.2023.100659_bb0190) 2004 Xu (10.1016/j.onehlt.2023.100659_bb0230) 2015; 197 Pappas (10.1016/j.onehlt.2023.100659_bb0045) 2009; 48 Pincus (10.1016/j.onehlt.2023.100659_bb0160) 2007; 45 Paul (10.1016/j.onehlt.2023.100659_bb0225) 2019; 5 Quindós (10.1016/j.onehlt.2023.100659_bb0040) 2019; 24 Castelo-Branco (10.1016/j.onehlt.2023.100659_bb0110) 2020; 58 Odiba (10.1016/j.onehlt.2023.100659_bb0235) 2022; 15 Katz (10.1016/j.onehlt.2023.100659_bb0100) 2021; 1985 Borman (10.1016/j.onehlt.2023.100659_bb0135) 2021; 59 Schindelin (10.1016/j.onehlt.2023.100659_bb0130) 2012; 9 Whaley (10.1016/j.onehlt.2023.100659_bb0055) 2016; 7 Borman (10.1016/j.onehlt.2023.100659_bb0015) 2021; 59 Wahyuningsih (10.1016/j.onehlt.2023.100659_bb0115) 2000; 38 Hamza (10.1016/j.onehlt.2023.100659_bb0200) 2008; 8 Fraser (10.1016/j.onehlt.2023.100659_bb0175) 2015 Gaitán-Cepeda (10.1016/j.onehlt.2023.100659_bb0075) 2015; 26 Burton (10.1016/j.onehlt.2023.100659_bb0165) 2011; 341 Akpan (10.1016/j.onehlt.2023.100659_bb0005) 2002; 78 Jayachandran (10.1016/j.onehlt.2023.100659_bb0085) 2016; 2016 Ingle (10.1016/j.onehlt.2023.100659_bb0150) 2017; 2 Rai (10.1016/j.onehlt.2023.100659_bb0050) 2022; 12 Matare (10.1016/j.onehlt.2023.100659_bb0140) 2017; 2017 González Gravina (10.1016/j.onehlt.2023.100659_bb0180) 2007; 12 Talukdar (10.1016/j.onehlt.2023.100659_bb0185) 2020; 16 Černáková (10.1016/j.onehlt.2023.100659_bb0020) 2022; 58 Chitapanarux (10.1016/j.onehlt.2023.100659_bb0080) 2021; 21 Mahdavi Omran (10.1016/j.onehlt.2023.100659_bb0215) 2018; 2018 White (10.1016/j.onehlt.2023.100659_bb0070) 1997; 41 Singh (10.1016/j.onehlt.2023.100659_bb0010) 2014; 18 Jain (10.1016/j.onehlt.2023.100659_bb0095) 2016; 10 Fothergill (10.1016/j.onehlt.2023.100659_bb0120) 2012 (10.1016/j.onehlt.2023.100659_bb0125) 2018 Sanguinetti (10.1016/j.onehlt.2023.100659_bb0195) 2015; 58 Tsao (10.1016/j.onehlt.2023.100659_bb0065) 2009; 53 WHO TEAM (10.1016/j.onehlt.2023.100659_bb0030) Xiang (10.1016/j.onehlt.2023.100659_bb0060) 2013; 13 Sonneborn (10.1016/j.onehlt.2023.100659_bb0145) 1999; 67 A.N. R, N.B. Rafiq (10.1016/j.onehlt.2023.100659_bb0035) 2022 Urbanek (10.1016/j.onehlt.2023.100659_bb0220) 2022; 11 Taylor (10.1016/j.onehlt.2023.100659_bb0155) 2023 Benito-Cruz (10.1016/j.onehlt.2023.100659_bb0025) 2016; 65 Carvalhinho (10.1016/j.onehlt.2023.100659_bb0210) 2012; 174 |
References_xml | – volume: 65 start-page: 204 year: 2016 end-page: 210 ident: bb0025 article-title: Oral Candida isolates and fluconazole susceptibility patterns in older Mexican women publication-title: Arch. Gerontol. Geriatr. contributor: fullname: Sánchez-Vargas – volume: 53 start-page: 1344 year: 2009 end-page: 1352 ident: bb0065 article-title: Relative contributions of the publication-title: Antimicrob. Agents Chemother. contributor: fullname: Raymond – volume: 59 start-page: e01811 year: 2021 end-page: e01820 ident: bb0015 article-title: Name Changes for Fungi of Medical Importance, 2018 to 2019 publication-title: J. Clin. Microbiol. contributor: fullname: Johnson – volume: 341 start-page: 71 year: 2011 end-page: 73 ident: bb0165 article-title: Misidentification of Candida parapsilosis as C famata in a clinical case of vertebral osteomyelitis publication-title: Am J Med Sci contributor: fullname: Shah – volume: 58 start-page: 896 year: 2020 end-page: 905 ident: bb0110 article-title: Azole resistance in Candida from animals calls for the one health approach to tackle the emergence of antimicrobial resistance publication-title: Med. Mycol. contributor: fullname: Sidrim – volume: 24 start-page: e172 year: 2019 end-page: e180 ident: bb0040 article-title: Therapeutic tools for oral candidiasis: current and new antifungal drugs publication-title: Med. Oral Patol. Oral Cir. Bucal. contributor: fullname: Eraso – volume: 10 start-page: ZC17 year: 2016 end-page: 20 ident: bb0095 article-title: The Oral carriage of Candida in Oral Cancer patients of Indian origin undergoing radiotherapy and/or chemotherapy publication-title: J. Clin. Diagn. Res. JCDR. contributor: fullname: Bhagalia – volume: 2017 start-page: 1 year: 2017 end-page: 5 ident: bb0140 article-title: Experimental germ tube induction in publication-title: Biomed. Res. Int. contributor: fullname: Robertson – volume: 18 start-page: S81 year: 2014 end-page: S85 ident: bb0010 article-title: Oral candidiasis: an overview publication-title: J. Oral Maxillofac. Pathol. JOMFP. contributor: fullname: Agrawal – volume: 7 start-page: 2173 year: 2016 ident: bb0055 article-title: Azole antifungal resistance in Candida albicans and emerging non-albicans Candida species publication-title: Front. Microbiol. contributor: fullname: Rogers – volume: 1985 start-page: 714 year: 2021 end-page: 718 ident: bb0100 article-title: Prevalence of candidiasis and oral candidiasis in COVID-19 patients: a cross-sectional pilot study from the patients’ registry in a large health center publication-title: Quintessence Int. Berl. Ger. contributor: fullname: Katz – year: 2018 ident: bb0125 article-title: M44: method for antifungal disk diffusion susceptibility testing of yeasts publication-title: Nielsen Bookdata, Place of Publication Not Identified – volume: 58 start-page: 2 year: 2015 end-page: 13 ident: bb0195 article-title: Antifungal drug resistance among publication-title: Mycoses. contributor: fullname: Lass-Flörl – start-page: 65 year: 2012 end-page: 74 ident: bb0120 article-title: Antifungal susceptibility testing: Clinical laboratory and standards institute (CLSI) methods publication-title: Interact. Yeasts Moulds Antifung contributor: fullname: Fothergill – volume: 13 start-page: 386 year: 2013 end-page: 393 ident: bb0060 article-title: mutations associated with azole resistance in clinical isolates of publication-title: FEMS Yeast Res. contributor: fullname: Ge – volume: 59 start-page: 253 year: 2021 end-page: 258 ident: bb0135 article-title: CHROMagarTM Candida plus: a novel chromogenic agar that permits the rapid identification of Candida auris publication-title: Med. Mycol. contributor: fullname: Johnson – volume: 12 start-page: E419 year: 2007 end-page: E423 ident: bb0180 article-title: Oral candidiasis in children and adolescents with cancer. Identification of Candida spp publication-title: Med. Oral Patol. Oral Cir. Bucal. contributor: fullname: Mesa – year: 2004 ident: bb0190 article-title: Interventions for preventing oral candidiasis for patients with cancer receiving treatment publication-title: The Cochrane Collaboration (Ed.), Cochrane Database Syst. Rev contributor: fullname: Clarkson – volume: 12 start-page: 1677 year: 2022 ident: bb0050 article-title: Nystatin effectiveness in Oral candidiasis treatment: a Systematic Review & Meta-Analysis of clinical trials publication-title: Life. contributor: fullname: Lapinska – year: 2022 ident: bb0030 article-title: WHO Fungal Priority Pathogens List to Guide Research, Development and Public Health Action contributor: fullname: WHO TEAM – volume: 2016 start-page: 8758461 year: 2016 ident: bb0085 article-title: Oral candidiasis among Cancer patients attending a tertiary Care Hospital in Chennai, South India: an evaluation of Clinicomycological association and antifungal susceptibility pattern publication-title: Can. J. Infect. Dis. Med. Microbiol. J. Can. Mal. Infect. Microbiol. Medicale. contributor: fullname: Jayachandran – volume: 78 start-page: 455 year: 2002 end-page: 459 ident: bb0005 article-title: Oral candidiasis publication-title: Postgrad. Med. J. contributor: fullname: Morgan – volume: 11 start-page: 1289 year: 2022 ident: bb0220 article-title: The role of ERG11 point mutations in the resistance of Candida albicans to fluconazole in the presence of lactate publication-title: Pathog. Basel Switz. contributor: fullname: Krasowska – year: 2022 ident: bb0035 article-title: Candidiasis publication-title: StatPearls contributor: fullname: A.N. R, N.B. Rafiq – volume: 8 start-page: 135 year: 2008 ident: bb0200 article-title: Species distribution and in vitro antifungal susceptibility of oral yeast isolates from Tanzanian HIV-infected patients with primary and recurrent oropharyngeal candidiasis publication-title: BMC Microbiol. contributor: fullname: Verweij – volume: 18 start-page: 24 year: 2018 ident: bb0205 article-title: Identification of uncommon oral yeasts from cancer patients by MALDI-TOF mass spectrometry publication-title: BMC Infect. Dis. contributor: fullname: Badali – volume: 38 start-page: 3016 year: 2000 end-page: 3021 ident: bb0115 article-title: Simple and rapid detection of publication-title: J. Clin. Microbiol. contributor: fullname: Schnitzler – volume: 67 start-page: 5514 year: 1999 end-page: 5517 ident: bb0145 article-title: Chlamydospore formation in publication-title: Infect. Immun. contributor: fullname: Ernst – volume: 9 start-page: 676 year: 2012 end-page: 682 ident: bb0130 article-title: Fiji: an open-source platform for biological-image analysis publication-title: Nat. Methods contributor: fullname: Cardona – volume: 58 start-page: 576 year: 2022 ident: bb0020 article-title: Prevalence and antifungal susceptibility profile of Oral Candida spp. isolates from a Hospital in Slovakia publication-title: Med. Kaunas Lith. contributor: fullname: Rodrigues – year: 2023 ident: bb0155 article-title: Oral candidiasis publication-title: StatPearls contributor: fullname: Raja – volume: 5 start-page: 1 year: 2019 end-page: 6 ident: bb0225 article-title: Extensive ERG11 mutations associated with fluconazole-resistant Candida albicans isolated from HIV-infected patients publication-title: Curr. Med. Mycol. contributor: fullname: Mohanram – volume: 21 start-page: 353 year: 2021 ident: bb0080 article-title: An underestimated pitfall of oral candidiasis in head and neck cancer patients undergoing radiotherapy: an observation study publication-title: BMC Oral Health contributor: fullname: Kittidachanan – volume: 6 start-page: 36157 year: 2016 ident: bb0105 article-title: Opportunistic fungal pathogen Candida glabrata circulates between humans and yellow-legged gulls publication-title: Sci. Rep. contributor: fullname: Ranque – start-page: myv085 year: 2015 ident: bb0175 article-title: Rapid identification of 6328 isolates of pathogenic yeasts using MALDI-ToF MS and a simplified, rapid extraction procedure that is compatible with the Bruker Biotyper platform and database publication-title: Med. Mycol. contributor: fullname: Johnson – volume: 50 start-page: 2780 year: 1982 end-page: 2784 ident: bb0090 article-title: Candida infections in patients with acute leukemia: ineffectiveness of nystatin prophylaxis and relationship between oropharyngeal and systemic candidiasis publication-title: Cancer. contributor: fullname: Ries – volume: 174 start-page: 69 year: 2012 end-page: 76 ident: bb0210 article-title: Susceptibilities of Candida albicans mouth isolates to antifungal agents, essentials oils and mouth rinses publication-title: Mycopathologia. contributor: fullname: Sampaio – volume: 41 start-page: 1482 year: 1997 end-page: 1487 ident: bb0070 article-title: Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus publication-title: Antimicrob. Agents Chemother. contributor: fullname: White – volume: 16 start-page: 209 year: 2020 ident: bb0185 article-title: Fungal profile and antifungal susceptibility pattern of candidiasis in esophageal cancer patients publication-title: J. Cancer Res. Ther. contributor: fullname: Kataki – volume: 2 start-page: 26 year: 2017 ident: bb0150 article-title: Chlamydospore specific proteins of Candida albicans publication-title: Data. contributor: fullname: Zore – volume: 45 start-page: 97 year: 2007 end-page: 121 ident: bb0160 article-title: Yeast identification – past, present, and future methods publication-title: Med. Mycol. contributor: fullname: Chatellier – volume: 197 start-page: 1087 year: 2015 end-page: 1093 ident: bb0230 article-title: ERG11 mutations and expression of resistance genes in fluconazole-resistant Candida albicans isolates publication-title: Arch. Microbiol. contributor: fullname: Li – volume: 26 start-page: 625 year: 2015 end-page: 632 ident: bb0075 article-title: Prevalence of oral candidiasis in HIV/AIDS children in highly active antiretroviral therapy era. A literature analysis publication-title: Int. J. STD AIDS contributor: fullname: Castillo – volume: 2018 start-page: 1 year: 2018 end-page: 6 ident: bb0215 article-title: In vitro antifungal susceptibility of publication-title: Biomed. Res. Int. contributor: fullname: Taghizadeh-Armaki – volume: 36 start-page: 1157 year: 1998 end-page: 1159 ident: bb0170 article-title: Chromogenic tube test for presumptive identification or confirmation of isolates as Candida albicans publication-title: J. Clin. Microbiol. contributor: fullname: Veal – volume: 15 start-page: 3111 year: 2022 end-page: 3133 ident: bb0235 article-title: A new variant of mutational and polymorphic signatures in the ERG11 gene of fluconazole-resistant Candida albicans publication-title: Infect. Drug Resist. contributor: fullname: Nwanguma – volume: 48 start-page: 503 year: 2009 end-page: 535 ident: bb0045 article-title: Clinical practice guidelines for the management of candidiasis: 2009 Update by the Infectious Diseases Society of America publication-title: Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. contributor: fullname: Infectious Diseases Society of America – volume: 2017 start-page: 1 year: 2017 ident: 10.1016/j.onehlt.2023.100659_bb0140 article-title: Experimental germ tube induction in Candida albicans : an evaluation of the effect of sodium bicarbonate on morphogenesis and comparison with pooled human serum publication-title: Biomed. Res. Int. doi: 10.1155/2017/1976273 contributor: fullname: Matare – volume: 2018 start-page: 1 year: 2018 ident: 10.1016/j.onehlt.2023.100659_bb0215 article-title: In vitro antifungal susceptibility of Candida species isolated from Iranian patients with denture stomatitis publication-title: Biomed. Res. Int. doi: 10.1155/2018/3086586 contributor: fullname: Mahdavi Omran – volume: 21 start-page: 353 year: 2021 ident: 10.1016/j.onehlt.2023.100659_bb0080 article-title: An underestimated pitfall of oral candidiasis in head and neck cancer patients undergoing radiotherapy: an observation study publication-title: BMC Oral Health doi: 10.1186/s12903-021-01721-x contributor: fullname: Chitapanarux – year: 2018 ident: 10.1016/j.onehlt.2023.100659_bb0125 article-title: M44: method for antifungal disk diffusion susceptibility testing of yeasts – volume: 5 start-page: 1 year: 2019 ident: 10.1016/j.onehlt.2023.100659_bb0225 article-title: Extensive ERG11 mutations associated with fluconazole-resistant Candida albicans isolated from HIV-infected patients publication-title: Curr. Med. Mycol. contributor: fullname: Paul – volume: 10 start-page: ZC17 year: 2016 ident: 10.1016/j.onehlt.2023.100659_bb0095 article-title: The Oral carriage of Candida in Oral Cancer patients of Indian origin undergoing radiotherapy and/or chemotherapy publication-title: J. Clin. Diagn. Res. JCDR. contributor: fullname: Jain – volume: 12 start-page: E419 year: 2007 ident: 10.1016/j.onehlt.2023.100659_bb0180 article-title: Oral candidiasis in children and adolescents with cancer. Identification of Candida spp publication-title: Med. Oral Patol. Oral Cir. Bucal. contributor: fullname: González Gravina – year: 2022 ident: 10.1016/j.onehlt.2023.100659_bb0035 article-title: Candidiasis contributor: fullname: A.N. R, N.B. Rafiq – volume: 26 start-page: 625 year: 2015 ident: 10.1016/j.onehlt.2023.100659_bb0075 article-title: Prevalence of oral candidiasis in HIV/AIDS children in highly active antiretroviral therapy era. A literature analysis publication-title: Int. J. STD AIDS doi: 10.1177/0956462414548906 contributor: fullname: Gaitán-Cepeda – volume: 11 start-page: 1289 year: 2022 ident: 10.1016/j.onehlt.2023.100659_bb0220 article-title: The role of ERG11 point mutations in the resistance of Candida albicans to fluconazole in the presence of lactate publication-title: Pathog. Basel Switz. doi: 10.3390/pathogens11111289 contributor: fullname: Urbanek – volume: 78 start-page: 455 year: 2002 ident: 10.1016/j.onehlt.2023.100659_bb0005 article-title: Oral candidiasis publication-title: Postgrad. Med. J. doi: 10.1136/pmj.78.922.455 contributor: fullname: Akpan – volume: 16 start-page: 209 year: 2020 ident: 10.1016/j.onehlt.2023.100659_bb0185 article-title: Fungal profile and antifungal susceptibility pattern of candidiasis in esophageal cancer patients publication-title: J. Cancer Res. Ther. doi: 10.4103/jcrt.JCRT_581_18 contributor: fullname: Talukdar – volume: 58 start-page: 2 year: 2015 ident: 10.1016/j.onehlt.2023.100659_bb0195 article-title: Antifungal drug resistance among Candida species: mechanisms and clinical impact publication-title: Mycoses. doi: 10.1111/myc.12330 contributor: fullname: Sanguinetti – volume: 8 start-page: 135 year: 2008 ident: 10.1016/j.onehlt.2023.100659_bb0200 article-title: Species distribution and in vitro antifungal susceptibility of oral yeast isolates from Tanzanian HIV-infected patients with primary and recurrent oropharyngeal candidiasis publication-title: BMC Microbiol. doi: 10.1186/1471-2180-8-135 contributor: fullname: Hamza – volume: 59 start-page: 253 year: 2021 ident: 10.1016/j.onehlt.2023.100659_bb0135 article-title: CHROMagarTM Candida plus: a novel chromogenic agar that permits the rapid identification of Candida auris publication-title: Med. Mycol. doi: 10.1093/mmy/myaa049 contributor: fullname: Borman – volume: 197 start-page: 1087 year: 2015 ident: 10.1016/j.onehlt.2023.100659_bb0230 article-title: ERG11 mutations and expression of resistance genes in fluconazole-resistant Candida albicans isolates publication-title: Arch. Microbiol. doi: 10.1007/s00203-015-1146-8 contributor: fullname: Xu – start-page: 65 year: 2012 ident: 10.1016/j.onehlt.2023.100659_bb0120 article-title: Antifungal susceptibility testing: Clinical laboratory and standards institute (CLSI) methods contributor: fullname: Fothergill – year: 2023 ident: 10.1016/j.onehlt.2023.100659_bb0155 article-title: Oral candidiasis contributor: fullname: Taylor – volume: 41 start-page: 1482 year: 1997 ident: 10.1016/j.onehlt.2023.100659_bb0070 article-title: Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.41.7.1482 contributor: fullname: White – volume: 67 start-page: 5514 year: 1999 ident: 10.1016/j.onehlt.2023.100659_bb0145 article-title: Chlamydospore formation in Candida albicans requires the Efg1p morphogenetic regulator publication-title: Infect. Immun. doi: 10.1128/IAI.67.10.5514-5517.1999 contributor: fullname: Sonneborn – volume: 12 start-page: 1677 year: 2022 ident: 10.1016/j.onehlt.2023.100659_bb0050 article-title: Nystatin effectiveness in Oral candidiasis treatment: a Systematic Review & Meta-Analysis of clinical trials publication-title: Life. doi: 10.3390/life12111677 contributor: fullname: Rai – volume: 15 start-page: 3111 year: 2022 ident: 10.1016/j.onehlt.2023.100659_bb0235 article-title: A new variant of mutational and polymorphic signatures in the ERG11 gene of fluconazole-resistant Candida albicans publication-title: Infect. Drug Resist. doi: 10.2147/IDR.S360973 contributor: fullname: Odiba – ident: 10.1016/j.onehlt.2023.100659_bb0030 contributor: fullname: WHO TEAM – volume: 13 start-page: 386 year: 2013 ident: 10.1016/j.onehlt.2023.100659_bb0060 article-title: Erg11 mutations associated with azole resistance in clinical isolates of Candida albicans publication-title: FEMS Yeast Res. doi: 10.1111/1567-1364.12042 contributor: fullname: Xiang – volume: 58 start-page: 896 year: 2020 ident: 10.1016/j.onehlt.2023.100659_bb0110 article-title: Azole resistance in Candida from animals calls for the one health approach to tackle the emergence of antimicrobial resistance publication-title: Med. Mycol. doi: 10.1093/mmy/myz135 contributor: fullname: Castelo-Branco – start-page: myv085 year: 2015 ident: 10.1016/j.onehlt.2023.100659_bb0175 article-title: Rapid identification of 6328 isolates of pathogenic yeasts using MALDI-ToF MS and a simplified, rapid extraction procedure that is compatible with the Bruker Biotyper platform and database publication-title: Med. Mycol. doi: 10.1093/mmy/myv085 contributor: fullname: Fraser – volume: 48 start-page: 503 year: 2009 ident: 10.1016/j.onehlt.2023.100659_bb0045 article-title: Clinical practice guidelines for the management of candidiasis: 2009 Update by the Infectious Diseases Society of America publication-title: Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. doi: 10.1086/596757 contributor: fullname: Pappas – year: 2004 ident: 10.1016/j.onehlt.2023.100659_bb0190 article-title: Interventions for preventing oral candidiasis for patients with cancer receiving treatment contributor: fullname: Worthington – volume: 6 start-page: 36157 year: 2016 ident: 10.1016/j.onehlt.2023.100659_bb0105 article-title: Opportunistic fungal pathogen Candida glabrata circulates between humans and yellow-legged gulls publication-title: Sci. Rep. doi: 10.1038/srep36157 contributor: fullname: Al-Yasiri – volume: 341 start-page: 71 year: 2011 ident: 10.1016/j.onehlt.2023.100659_bb0165 article-title: Misidentification of Candida parapsilosis as C famata in a clinical case of vertebral osteomyelitis publication-title: Am J Med Sci doi: 10.1097/MAJ.0b013e3181f54dab contributor: fullname: Burton – volume: 18 start-page: S81 year: 2014 ident: 10.1016/j.onehlt.2023.100659_bb0010 article-title: Oral candidiasis: an overview publication-title: J. Oral Maxillofac. Pathol. JOMFP. doi: 10.4103/0973-029X.141325 contributor: fullname: Singh – volume: 50 start-page: 2780 year: 1982 ident: 10.1016/j.onehlt.2023.100659_bb0090 article-title: Candida infections in patients with acute leukemia: ineffectiveness of nystatin prophylaxis and relationship between oropharyngeal and systemic candidiasis publication-title: Cancer. doi: 10.1002/1097-0142(19821215)50:12<2780::AID-CNCR2820501215>3.0.CO;2-P contributor: fullname: DeGregorio – volume: 45 start-page: 97 year: 2007 ident: 10.1016/j.onehlt.2023.100659_bb0160 article-title: Yeast identification – past, present, and future methods publication-title: Med. Mycol. doi: 10.1080/13693780601059936 contributor: fullname: Pincus – volume: 7 start-page: 2173 year: 2016 ident: 10.1016/j.onehlt.2023.100659_bb0055 article-title: Azole antifungal resistance in Candida albicans and emerging non-albicans Candida species publication-title: Front. Microbiol. contributor: fullname: Whaley – volume: 2016 start-page: 8758461 year: 2016 ident: 10.1016/j.onehlt.2023.100659_bb0085 article-title: Oral candidiasis among Cancer patients attending a tertiary Care Hospital in Chennai, South India: an evaluation of Clinicomycological association and antifungal susceptibility pattern publication-title: Can. J. Infect. Dis. Med. Microbiol. J. Can. Mal. Infect. Microbiol. Medicale. contributor: fullname: Jayachandran – volume: 65 start-page: 204 year: 2016 ident: 10.1016/j.onehlt.2023.100659_bb0025 article-title: Oral Candida isolates and fluconazole susceptibility patterns in older Mexican women publication-title: Arch. Gerontol. Geriatr. doi: 10.1016/j.archger.2016.04.001 contributor: fullname: Benito-Cruz – volume: 174 start-page: 69 year: 2012 ident: 10.1016/j.onehlt.2023.100659_bb0210 article-title: Susceptibilities of Candida albicans mouth isolates to antifungal agents, essentials oils and mouth rinses publication-title: Mycopathologia. doi: 10.1007/s11046-012-9520-4 contributor: fullname: Carvalhinho – volume: 2 start-page: 26 year: 2017 ident: 10.1016/j.onehlt.2023.100659_bb0150 article-title: Chlamydospore specific proteins of Candida albicans publication-title: Data. doi: 10.3390/data2030026 contributor: fullname: Ingle – volume: 1985 start-page: 714 issue: 52 year: 2021 ident: 10.1016/j.onehlt.2023.100659_bb0100 article-title: Prevalence of candidiasis and oral candidiasis in COVID-19 patients: a cross-sectional pilot study from the patients’ registry in a large health center publication-title: Quintessence Int. Berl. Ger. contributor: fullname: Katz – volume: 24 start-page: e172 year: 2019 ident: 10.1016/j.onehlt.2023.100659_bb0040 article-title: Therapeutic tools for oral candidiasis: current and new antifungal drugs publication-title: Med. Oral Patol. Oral Cir. Bucal. contributor: fullname: Quindós – volume: 38 start-page: 3016 year: 2000 ident: 10.1016/j.onehlt.2023.100659_bb0115 article-title: Simple and rapid detection of Candida albicans DNA in serum by PCR for diagnosis of invasive candidiasis publication-title: J. Clin. Microbiol. doi: 10.1128/JCM.38.8.3016-3021.2000 contributor: fullname: Wahyuningsih – volume: 53 start-page: 1344 year: 2009 ident: 10.1016/j.onehlt.2023.100659_bb0065 article-title: Relative contributions of the Candida albicans ABC transporters Cdr1p and Cdr2p to clinical azole resistance publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.00926-08 contributor: fullname: Tsao – volume: 9 start-page: 676 year: 2012 ident: 10.1016/j.onehlt.2023.100659_bb0130 article-title: Fiji: an open-source platform for biological-image analysis publication-title: Nat. Methods doi: 10.1038/nmeth.2019 contributor: fullname: Schindelin – volume: 18 start-page: 24 year: 2018 ident: 10.1016/j.onehlt.2023.100659_bb0205 article-title: Identification of uncommon oral yeasts from cancer patients by MALDI-TOF mass spectrometry publication-title: BMC Infect. Dis. doi: 10.1186/s12879-017-2916-5 contributor: fullname: Aslani – volume: 58 start-page: 576 year: 2022 ident: 10.1016/j.onehlt.2023.100659_bb0020 article-title: Prevalence and antifungal susceptibility profile of Oral Candida spp. isolates from a Hospital in Slovakia publication-title: Med. Kaunas Lith. contributor: fullname: Černáková – volume: 59 start-page: e01811 year: 2021 ident: 10.1016/j.onehlt.2023.100659_bb0015 article-title: Name Changes for Fungi of Medical Importance, 2018 to 2019 publication-title: J. Clin. Microbiol. doi: 10.1128/JCM.01811-20 contributor: fullname: Borman – volume: 36 start-page: 1157 year: 1998 ident: 10.1016/j.onehlt.2023.100659_bb0170 article-title: Chromogenic tube test for presumptive identification or confirmation of isolates as Candida albicans publication-title: J. Clin. Microbiol. doi: 10.1128/JCM.36.4.1157-1159.1998 contributor: fullname: Merlino |
SSID | ssj0001528525 |
Score | 2.332001 |
Snippet | In the nature, Candida species are normal inhabitants and can be observed in a wide variety of vertebrates. In humans, especially for cancer patients who fall... In the nature, species are normal inhabitants and can be observed in a wide variety of vertebrates. In humans, especially for cancer patients who fall prey to... In the nature, Candida species are normal inhabitants and can be observed in a wide variety of vertebrates. In humans, especially for cancer patients who fall... |
SourceID | doaj pubmedcentral proquest crossref pubmed elsevier |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 100659 |
SubjectTerms | Antifungal agents Candida species Drug-resistance susceptibility ERG11 Research Paper |
SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV25btwwECUSVwGCIHcUJwEDpBUiUhKP0idcpcmBdMTwkL05uMbuqvDfm0NKi924cJNGAiRCIjlDzZB675GQT975MLTa1mxwou7awGptFauHIUgVrHJ9Fnu--Cq__FSnZyiTs93qCzFhRR64dNznFAFhUK1ttBuQ9QlMOg5OpjilQ-8Lj7yRO5Opwg_mquf9zJXLgK5lDFd_ED7JW8QGCJQn3YlFWbJ_LyTdTTn_RU7uhKLzp-TJlEPSo1L3Z-RBiM_J47IARwuv6AX5jeJMkClFFKKnfjVe0vW4zjCWjIi9ocuBzsxIeoL8Fg8UqZdp9kwXkUbAPQ5gdRMv00OpQwdZ0UmJNZf4sQibCH9fku_nZ99OLuppZ4XadVJvatc7pjRLR8ATyva59LXxgbXQcN2knu6UUKCt98IlCyovhQ1CNSDShMm3r8hBTP35htCU8KkgNChofDfIDjiHHry2om0sZ7Yi9dzH5roIaJgZWfbLFJsYtIkpNqnIMRpiWxblr_OF5BRmcgpzn1NURM5mNFMmUTKE9KjFPa__OFvdpIGGf08ghuW4NlynuWkv0hewIq-LF2wriTKHumVdRdSef-y1Yv9OXFxlMW-GC0lSqrf_o92H5FFqS1egbO_IwWY1hvfk4dqPH_L4uAXTXhb5 priority: 102 providerName: Directory of Open Access Journals |
Title | Prevalence and drug susceptibility of clinical Candida species in nasopharyngeal cancer patients in Vietnam |
URI | https://dx.doi.org/10.1016/j.onehlt.2023.100659 https://www.ncbi.nlm.nih.gov/pubmed/38179314 https://search.proquest.com/docview/2928956832 https://pubmed.ncbi.nlm.nih.gov/PMC10761778 https://doaj.org/article/710af83b09cf4226a17c2ac71299e5d7 |
Volume | 18 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jj9MwFLbonJAQYicsIyNxzTR2Ei9HKDOaCwixCXGxnpd0AlN3lDaH-fd4aUYtHJC4JFLiOLHfi_1e8n2fEXptjXVdLXVJOsPKpnaklFqQsuscF04L0yax5_PP_MN38e40yuSwiQuTQPtG9yf-cnXi-4uErbxamfmEE5t_fL8gMfnmXMxnaBaCw70cPXODqWhpO_HkEphr7d3FZYRO0jriAliUJt2bh5Jc_8F09He4-Sdqcm8aOruH7u7iR_wmP-d9dMv5B-hO_viGM6foIfoVhZkg0YkweIvtMC7xZtwkCEtCw17jdYcnViReRG6LBRxplyFzxr3HHuL6BjBc-2WoFJvoHAPeqbCmEt96t_WweoS-np1-WZyXu1UVStNwuS1Na4iQJGwh7qJknwkjjXWkhorKqmtoI5gAqa1lJlhPWM60Y6ICFpIlWz9GRz7051OEQ7AnHJMgoLJNxxugFFqwUrO60pToApVTH6urLJ6hJlTZT5VtoqJNVLZJgd5GQ9yUjdLX6cB6WKqdA6gQEkEnal1J00UaMBBuKBgeAhfpWssLxCczql0UkaODUFX_j9u_mqyuwksW_5yAd-txo6gMeWnLwuhXoCfZC24eMkocypo0BRIH_nHQisMzwa-TkPfkx8_-_9Ln6HZoQZPBay_Q0XYY3Us029jxOH1eOE7vRtj-aD_9BlDuGHM |
link.rule.ids | 230,315,729,782,786,866,887,2107,27934,27935,53802,53804 |
linkProvider | National Library of Medicine |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jb9QwFLZoOYCEyloaViNxTSd2Ei9HGFoNoq2QKIib5S3TQMdTZSaH_nu8JNUMHJB6SaTYWZz3bL-XfN9nAN4bbWxTcpWjRpO8Ki3KuWIobxpLmVVM11HsefaNnv1kn46CTA4ZuTARtK9Ve-guF4euvYjYyquFnow4scnX0ykKyTelbLID7voOW-CNLD2xgzGrcT0y5SKca-nsxWUAT-IyIANIECfdmImiYP_WhPRvwPk3bnJjIjp-eNsmPAJ7Q-gJP6Tyx-COdU_Ag_TdDiY60lPwO2g6ychEgtIZaLp-Dlf9KqJfIpD2Gi4bOBIq4TTQYoyEgbHpk27YOuhkWBpBdtdu7i8KdfCrDg4CrrHGj9aunVw8A9-Pj86ns3xYkCHXFeXrXNcaMY78VoZdUPvTfpAyFpWywLxoKlwxwiRXxhDtDc8MJcoSVkji8yxT7oNd5w1xAKCPE5klXDJZmKqhlcRY1tJwRcpCYaQykI_GEVdJd0OMgLRfIhlTBGOKZMwMfAwWvKkbVLPjgWU3F8OLFz6akg0rVcF1ExjEElGNpaY-5uG2NjQDdLS_GAKQFFj4S7X_uf270V2E75_hp4t0dtmvBOY-pa2JHzgz8Dy5z81DBnVEXqIqA2zLsbZasV3i_SlqgI_-8-L2p74F92bnpyfi5PPZl5fgvm9NlTBwr8Duuuvta7CzMv2b2LX-AGoXLDw |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Jb9QwFLZokRASYi-E1Uhc04mdxAs3mHZUBFSVWMTN8joNdDyjzOTQf4_tJNUMHJDgkkiJ48R5z_Z7yfd9BuC10ca6kqscOU3yqrQo54qh3DlLmVVM10ns-eQzPf3Ojo6jTM6bkQuTQPtaNYf-YnHom_OErVwt9GTEiU3OPk1RTL4pZZOVcZM9cD102qLaytR7hjBmNa5HtlyCdC29Pb-IAEpcRnQAiQKlW7NREu3fmZT-DDp_x05uTUazO__TjLvg9hCCwrd9mXvgmvX3wa3--x3saUkPwM-o7SQTIwlKb6Bpuzlcd-uEgkmA2ku4dHAkVsJppMcYCSNzMyTfsPHQy7hEgmwv_TxUCnX0rxYOQq6pxLfGbrxcPARfZ8dfpif5sDBDrivKN7muNWIcha2Mu6j6p8NgZSwqZYF54SpcMcIkV8YQHRyAGUqUJayQJORbpjwA-z4Y4zGAIV5klnDJZGEqRyuJsayl4YqUhcJIZSAfDSRWvf6GGIFpP0RvUBENKnqDZuBdtOJV2aienQ4s27kYXr4IUZV0rFQF1y4yiSWiGktNQ-zDbW1oBujoA2IIRPoAI1TV_OX2r0aXEaGfxp8v0ttltxaYh9S2JmEAzcCj3oWuHjKqJPISVRlgO86104rdM8Gnkhb46ENP_v3Sl-DG2dFMfHx_-uEpuBkaU_VQuGdgf9N29jnYW5vuRepdvwC8bi68 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prevalence+and+drug+susceptibility+of+clinical+Candida+species+in+nasopharyngeal+cancer+patients+in+Vietnam&rft.jtitle=One+health&rft.au=Nguyen%2C+Bac+V.G.&rft.au=Nguyen%2C+Hau+H.N.&rft.au=Vo%2C+Thanh-Hoa&rft.au=Le%2C+Minh-Tri&rft.date=2024-06-01&rft.pub=Elsevier+B.V&rft.issn=2352-7714&rft.eissn=2352-7714&rft.volume=18&rft_id=info:doi/10.1016%2Fj.onehlt.2023.100659&rft.externalDocID=S2352771423001799 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2352-7714&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2352-7714&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2352-7714&client=summon |